Current Understanding of Epigenetics Driven Therapeutic Strategies in Colorectal Cancer Management
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
21
Page:
1882-1894
Author(s):
Dikshita Deka, Marco Scarpa, Alakesh Das, Surajit Pathak and Antara Banerjee*
The Assessment of Some Metabolic Markers by Combination of Ursolic Acid Supplementation and Resistance Training in Young Older Obese Women
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
21
Page:
1912-1919
Author(s):
Ehsan Asghari, Seyyed Reza Attarzadeh Hosseini, Mina Kiania, Tahereh Farkhondeh, Hamid Arazi and Saeed Samarghandian*
Investigation of ACE rs4646994, MTHFR rs1801133 and VDR rs2228570 Genotypes in Jordanian Patients with Fibromyalgia Syndrome
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
21
Page:
1920-1928
Author(s):
Raida Khalil, Wajdy J. Al-Awaida, Hamzeh J. Al-Ameer*, Yazun Jarrar, Amer Imraish, Omar Al Bawareed, Rand Qawadri, Farah Al Madhoon and Loiy Obeidat
The Skeletal Effects of Gonadotropin-Releasing Hormone Antagonists: A Concise Review
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
21
Page:
1713-1720
Author(s):
Nur-Vaizura Mohamad, Soelaiman Ima-Nirwana and Kok-Yong Chin*
Angiotensin II-Vasopressin Interactions in The Regulation of Cardiovascular Functions. Evidence for an Impaired Hormonal Sympathetic Reflex in Hypertension and Congestive Heart Failure
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
21
Page:
1830-1844
Author(s):
Michele Iovino, Giuseppe Lisco, Vito Angelo Giagulli, Aldo Vanacore, Alberto Pesce, Edoardo Guastamacchia, Giovanni De Pergola and Vincenzo Triggiani*
Triptolide Improves Renal Injury in Diabetic Nephropathy Rats through TGF-β1/Smads Signal Pathway
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
21
Page:
1905-1911
Author(s):
Ruoyu Pang* and Donghai Gu
Safety and Efficacy of Teplizumab for Treatment of Type One Diabetes Mellitus: A Systematic Review and Meta-Analysis
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
21
Page:
1895-1904
Author(s):
Anas Zakarya Nourelden, Alaa Ahmed Elshanbary, Loalo'a El-Sherif, Amira Yasmine Benmelouka, Hagar Ismail Rohim, Sara Kamel Helmy, Merhan Kamal Sayed, Ammar Ismail, Ahmed Said Ali, Khaled Mohamed Ragab and Mohamed Sayed Zaazouee*
Chronic Diseases and COVID-19: A Review
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
21
Page:
1781-1803
Author(s):
Mohammed Ajebli, Ayoub Amssayef, Mourad Akdad, Youness Algharrass, Abdelaadim Babakhouya, Dris Ghanimi and Mohamed Eddouks*
Hypersensitivity to Vitamins with a Focus on Immediate-Type Reactions: Food or Drug Allergy?
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
21
Page:
1804-1816
Author(s):
Gianfranco Calogiuri*, Lene H. Garvey, Eustachio Nettis, Francesco Casciaro, Shirina Alsowaidi, Caterina Foti and Angelo Vacca
Angiotensin-Converting Enzyme 2 Roles in the Pathogenesis of COVID-19
Journal:
Current Hypertension Reviews
Volume:
17
Page:
207-216
Author(s):
Azra Kenarkoohi, Maryam Maleki, Tahereh Safari, Mohammad Reza Kaffashian, Fateme Saljoughi and Shahla Sohrabipour*